AZS22-8b Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
AZS22-8b antibody; 22 kDa alpha-zein 8b antibody; 22 kDa zein 22C2 antibody; Zein-alpha 22C2 antibody; Fragment antibody
Target Names
AZS22-8b
Uniprot No.

Target Background

Function
Zeins are the primary storage proteins found in seeds.
Database Links

UniGene: Zm.103594

Protein Families
Zein family

Q&A

What is the AZS22-8b Antibody and what is its target protein?

The AZS22-8b antibody is a rabbit polyclonal antibody specifically developed against recombinant Zea mays (maize) AZS22-8b protein . The target protein is part of the α-zein 22-kD subfamily, which belongs to the prolamin class of seed storage proteins in maize. The AZS22-8b is closely related to the larger azs22 gene family expressed during endosperm development in maize . This antibody has been developed for research use only and is not intended for diagnostic or therapeutic applications .

What are the optimal storage conditions for maintaining AZS22-8b antibody activity?

For optimal preservation of antibody function, the AZS22-8b antibody should be stored at either -20°C or -80°C upon receipt. It's critical to avoid repeated freeze-thaw cycles which can severely compromise antibody activity . The antibody is provided in a storage buffer containing 0.03% Proclin 300 as a preservative, along with 50% glycerol and 0.01M PBS at pH 7.4, which helps maintain stability during storage . For laboratories conducting long-term studies, aliquoting the antibody before freezing is recommended to minimize freeze-thaw cycles.

What applications has the AZS22-8b antibody been validated for?

The AZS22-8b antibody has been specifically tested and validated for:

ApplicationValidation Status
ELISATested
Western BlotTested

The antibody has been affinity-purified using the antigen, which ensures identification specificity when used in these applications . While these are the validated applications, researchers should conduct preliminary tests when adapting the antibody for other techniques such as immunohistochemistry or immunoprecipitation.

What is the relationship between AZS22-8b and the zein protein family in maize?

AZS22-8b is part of the α-zein 22-kD subfamily in maize. The Z1C subfamily, to which AZS22-8b is related, consists of 16 genes, with six being expressed during endosperm development (including azs22.4, azs22.7, azs22.8, azs22.9, azs22.19, and fl2-azs22.16) . The azs22.8 gene specifically accounts for approximately 13% of the genes belonging to the Z1C subfamily and its expression peaks approximately 18 days after pollination, concurrent with the peak expression of the fl2 gene . This suggests a coordinated role in α-zein synthesis during seed development.

How can researchers optimize Western blot protocols specifically for AZS22-8b detection?

When optimizing Western blot protocols for AZS22-8b detection, researchers should consider the following methodological approach:

Sample Preparation:

  • Extract zein proteins using the method described by Das et al., which has been validated for zein isolation

  • Quantify protein using Bio-Rad protein assay following manufacturer's protocol

  • Use approximately 5 μg of total protein for 15% SDS-PAGE analysis

Electrophoresis Conditions:

  • Employ 15% SDS-PAGE for optimal separation of zein proteins

  • Run the gel using a protein mini apparatus (Bio-Rad or equivalent)

  • Fix the gel using TCA and stain with EzBlue (Sigma-Aldrich) for total protein visualization

Transfer and Detection:

  • Use PVDF membrane rather than nitrocellulose due to the hydrophobic nature of zein proteins

  • Optimize primary antibody dilution (starting from 1:1000)

  • Use anti-rabbit HRP-conjugated secondary antibody

  • Include appropriate positive controls (recombinant AZS22-8b protein) and negative controls (pre-immune serum)

Researchers should note that the hydrophobic nature of zein proteins can cause aggregation during sample preparation, so inclusion of sufficient detergent is critical for accurate results.

What is the role of AZS22-8b in relation to the Opaque2 (O2) transcription factor regulatory network?

The relationship between AZS22-8b and the Opaque2 (O2) transcription factor represents a complex regulatory network in maize endosperm development:

  • O2 is a basic leucine zipper (bZIP) transcription factor that primarily activates genes encoding the α-zein 22-kD subfamily .

  • The azs22 gene cluster, which includes genes related to AZS22-8b, contains both intact genes and pseudogenes, many of which possess a conserved O2-box located approximately 300 bp upstream of their ATG translational start codon .

  • This O2-box serves as the binding site for the O2 transcription factor, while a prolamine box (P-box) positioned 20 bp upstream of the O2-box is bound by the prolamine binding factor, which contains a DOF domain and can cooperate with O2 in regulating transcription .

  • Chromatin immunoprecipitation (ChIP) assays have demonstrated that O2 binding to the promoters of azs22 genes correlates with RNA polymerase II recruitment and gene activation during endosperm development .

  • The binding of O2 to azs22 gene promoters is accompanied by specific histone modifications, particularly H3K9 and H3K14 acetylation, which are markers of active transcription .

Researchers studying this regulatory network should consider that mutations in the O2-box, such as a C-to-A transversion in the ACGT core sequence, can significantly reduce O2 binding efficiency and consequently impact the expression of the corresponding gene .

How can AZS22-8b antibody be used to investigate developmental expression patterns in maize endosperm?

To investigate developmental expression patterns using the AZS22-8b antibody, researchers should implement the following methodological approach:

Tissue Sampling Strategy:

  • Collect endosperm samples at specific developmental timepoints (8, 12, 15, and 23 days after pollination) to capture the full expression pattern

  • Include wild-type and relevant mutant samples (e.g., o2 mutants) for comparative analysis

  • Process samples immediately or flash-freeze in liquid nitrogen to preserve protein integrity

Experimental Techniques:

  • Western Blot Analysis:

    • Extract proteins using standard zein extraction methods

    • Run 5 μg of protein on 15% SDS-PAGE gels

    • Normalize loading using constitutive proteins like actin

    • Compare expression across developmental stages quantitatively

  • Immunohistochemistry:

    • Section fixed endosperm tissue at 10-15 μm thickness

    • Use the AZS22-8b antibody (1:100-1:500 dilution range)

    • Include cellular markers to identify specific endosperm domains

    • Perform co-localization studies with other zein proteins to understand spatial organization

  • Chromatin Immunoprecipitation (ChIP):

    • If studying promoter regulation, combine with ChIP to analyze histone modifications

    • Compare acetylation patterns (H3K9ac, H3K14ac) across developmental stages

    • Correlate protein expression with chromatin modification patterns

This approach allows researchers to create a comprehensive developmental expression profile of AZS22-8b and understand its regulation in the context of endosperm development.

What strategies can be employed to investigate potential post-translational modifications of AZS22-8b protein?

Investigating post-translational modifications (PTMs) of AZS22-8b requires a multi-faceted analytical approach:

Initial PTM Profiling:

  • Iso-Electric Focusing (IEF) Analysis:

    • Subject 5 μg of extracted proteins to IEF gel analysis using a Multiphor II apparatus or equivalent

    • Use gels with a pH range of 3-10, run with 15 W constant power for 3 hours at 10°C

    • Compare migration patterns with theoretical isoelectric point to identify potential charge-modifying PTMs

  • Mass Spectrometry Analysis:

    • Immunoprecipitate AZS22-8b using the antibody

    • Digest with trypsin and analyze by LC-MS/MS

    • Search for common modifications such as phosphorylation, acetylation, and glycosylation

    • Use neutral loss scanning to detect phosphorylation events

Functional Validation of PTMs:

  • Generate phospho-specific or acetyl-specific antibodies for identified modification sites

  • Compare PTM patterns between different developmental stages and in response to stress conditions

  • Use phosphatase or deacetylase treatments to confirm the nature of modifications

PTM and Protein Localization:

  • Investigate whether PTMs affect protein localization within the endosperm cells

  • Compare distribution patterns of modified and unmodified forms using fractionation techniques

This systematic approach allows for comprehensive characterization of the PTM landscape of AZS22-8b and provides insights into how these modifications might regulate protein function during endosperm development.

How does the specificity of AZS22-8b antibody compare with other antibodies targeting related zein proteins?

When evaluating the specificity of AZS22-8b antibody compared to other zein-targeting antibodies, researchers should consider several critical factors:

Comparative Specificity Analysis:

AntibodyTarget ProteinCross-ReactivityApplications
AZS22-8bAZS22-8b zein proteinLimited to α-zein 22-kD subfamilyELISA, WB
AZS22-8AZS22-8 zein proteinSimilar profile to AZS22-8bELISA, WB
ACSS2Acetyl-CoA synthetaseHuman specific, not relevant for zein studiesIP, various human applications

Validation Methods for Specificity:

  • Western Blot Analysis with Recombinant Proteins:

    • Express individual recombinant zein proteins

    • Test reactivity of AZS22-8b antibody against each protein

    • Determine cross-reactivity profile quantitatively

  • Immunodepleton Experiments:

    • Pre-incubate antibody with purified AZS22-8b protein

    • Use depleted antibody in Western blots or immunostaining

    • Absence of signal confirms specificity

  • Genetic Validation:

    • Use null mutants or RNAi lines for AZS22-8b

    • Confirm absence of antibody binding in these genetic backgrounds

This methodical approach to specificity validation ensures reliable experimental results when using the AZS22-8b antibody for research applications.

What are the best practices for using AZS22-8b antibody in chromatin immunoprecipitation studies to investigate gene regulation?

For researchers employing AZS22-8b antibody in chromatin immunoprecipitation (ChIP) studies to investigate gene regulation, the following best practices should be implemented:

Sample Preparation Protocol:

  • Chromatin Extraction:

    • Harvest endosperm tissue at appropriate developmental stages (8, 15, and 23 days after pollination)

    • Cross-link proteins to DNA using 1% formaldehyde for 10 minutes at room temperature

    • Quench with 0.125 M glycine

    • Extract and sonicate chromatin to fragments of 200-500 bp

  • Immunoprecipitation Optimization:

    • Use 5-10 μg of AZS22-8b antibody per ChIP reaction

    • Include positive controls (anti-histone H3) and negative controls (pre-immune serum)

    • Perform preliminary titration experiments to determine optimal antibody concentration

    • Pre-clear chromatin with protein A/G beads to reduce background

Analysis of ChIP Results:

  • PCR Amplification:

    • Design primers to amplify regions of interest in zein gene promoters

    • Include primers for O2-box regions, which are found approximately 300 bp upstream of the ATG translational start codon

    • Include controls for non-specific binding (gene desert regions)

  • Data Interpretation Framework:

    • Compare binding profiles across developmental stages

    • Correlate with histone modification patterns (H3K9ac, H3K14ac)

    • Analyze in parallel with RNA polymerase II binding data

    • Connect binding data with gene expression levels

  • Integration with Epigenetic Data:

    • Analyze binding in relation to chromatin modifications

    • Compare wild-type and o2 mutant backgrounds to understand regulatory relationships

    • Correlate binding with DNA methylation patterns

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.